Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays

Molecular and Cellular Proteomics

Volumn 11, Issue 9, 2012, Pages 669-680

  Hu, Chao Jun ^a   Song, Guang ^b,e   Huang, Wei ^b,e   Liu, Guo Zhen ^c   Deng, Chui Wen ^a   Zeng, Hai Pan ^c   Wang, Li ^a   Zhang, Feng Chun ^a   Zhang, Xuan ^a   Jeong, Jun Seop ^d   Blackshaw, Seth ^d   Jiang, Li Zhi ^d   Zhu, Heng ^d   Wu, Lin ^b,e   Li, Yong Zhe ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b China National Center for Bioinformation   (China)

^c Beijing Protein Innovation Co Ltd   (China)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 1 PROTEIN; AUTOANTIGEN; BTB DOMAIN CONTAINING PROTEIN 2; HEXOKINASE 1; KELCH LIKE PROTEIN 12; KELCH LIKE PROTEIN 7; PROTEOME; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADULT; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN MICROARRAY; RHEUMATOID ARTHRITIS; SCREENING; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; ARGONAUTE PROTEINS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; EUKARYOTIC INITIATION FACTORS; FEMALE; HEXOKINASE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOME; REPRESSOR PROTEINS; SENSITIVITY AND SPECIFICITY; ZINC FINGERS;

EUKARYOTA; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84865772818     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.015529     Document Type: Article

References (98)

1. Selmi, C., Bowlus, C. L., Gershwin, M. E., and Coppel, R. L. (2011) Primary biliary cirrhosis. Lancet 377, 1600-1609
2. Kaplan, M. M., and Gershwin, M. E. (2005) Primary biliary cirrhosis. N. Engl. J. Med. 353, 1261-1273
3. Prince, M. I., and James, O. F. (2003) The epidemiology of primary biliary cirrhosis. Clin. Liver Dis. 7, 795-819
4. Hohenester, S., Oude-Elferink, R. P., and Beuers, U. (2009) Primary biliary cirrhosis. Semin. Immunopathol. 31, 283-307
5. Milkiewicz, P. (2008) Liver transplantation in primary biliary cirrhosis. Clin. Liver Dis. 12, 461-472
6. Gershwin, M. E., Selmi, C., Worman, H. J., Gold, E. B., Watnik, M., Utts, J., Lindor, K. D., Kaplan, M. M., and Vierling, J. M. (2005) Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients. Hepatology 42, 1194-1202
7. Invernizzi, P., Pasini, S., Selmi, C., Gershwin, M. E., and Podda, M. (2009) Female predominance and X chromosome defects in autoimmune diseases. J. Autoimmun. 33, 12-16
8. Poupon, R. (2010) Primary biliary cirrhosis: A 2010 update. J. Hepatol. 52, 745-758
9. Wong, G. L., Hui, A. Y., Wong, V. W., Chan, F. K., Sung, J. J., and Chan, H. L. (2005) A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients. Am. J. Gastroenterol. 100, 2205-2211
10. Kumagi, T., Alswat, K., Hirschfield, G. M., and Heathcote, J. (2008) New insights into autoimmune liver diseases. Hepatol. Res. 38, 745-761
11. Fussey, S. P., Bassendine, M. F., Fittes, D., Turner, I. B., James, O. F., and Yeaman, S. J. (1989) The E1 α and β subunits of the pyruvate dehydrogenase complex are M2′d′ and M2′e′ autoantigens in primary biliary cirrhosis. Clin. Sci. 77, 365-368
12. Fussey, S. P., Bassendine, M. F., James, O. F., and Yeaman, S. J. (1989) Characterisation of the reactivity of autoantibodies in primary biliary cirrhosis. FEBS Lett. 246, 49-53
13. Van de Water, J., Cooper, A., Surh, C. D., Coppel, R., Danner, D., Ansari, A., Dickson, R., and Gershwin, M. E. (1989) Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N. Engl. J. Med. 320, 1377-1380
14. Leung, P. S., Coppel, R. L., Ansari, A., Munoz, S., and Gershwin, M. E. (1997) Antimitochondrial antibodies in primary biliary cirrhosis. Semin. Liver Dis. 17, 61-69
15. Lindenborn-Fotinos, J., Baum, H., and Berg, P. A. (1985) Mitochondrial antibodies in primary biliary cirrhosis: Species and nonspecies specific determinants of M2 antigen. Hepatology 5, 763-769
16. Miyakawa, H., Tanaka, A., Kikuchi, K., Matsushita, M., Kitazawa, E., Kawaguchi, N., Fujikawa, H., and Gershwin, M. E. (2001) Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 34, 243-248
17. Leung, P. S., Rossaro, L., Davis, P. A., Park, O., Tanaka, A., Kikuchi, K., Miyakawa, H., Norman, G. L., Lee, W., and Gershwin, M. E. (2007) Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis. Hepatology 46, 1436-1442
18. Chung, L., and Utz, P. J. (2004) Antibodies in scleroderma: Direct pathogenicity and phenotypic associations. Curr. Rheumatol. Rep. 6, 156-163
19. O'Brien, C., Joshi, S., Feld, J. J., Guindi, M., Dienes, H. P., and Heathcote, E. J. (2008) Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 48, 550-556
20. Nardi, N., Brito-Zerón, P., Ramos-Casals, M., Aguiló, S., Cervera, R., Ingelmo, M., and Font, J. (2006) Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren's syndrome: Prevalence and clinical significance in 335 patients. Clin. Rheumatol. 25, 341-346
21. Ramos-Casals, M., Pares, A., Jara, L. J., Solans, R., Viñas, O., Vázquez, P., Sánchez-Tapias, J. M., Rodés, J., and Font, J. (2005) Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: Description of 18 cases and review of the literature. J. Viral. Hepat. 12, 648-654
22. Montano-Loza, A. J., Carpenter, H. A., and Czaja, A. J. (2008) Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J. Clin. Gastroenterol. 42, 1047-1053
23. Klein, R., Wiebel, M., Engelhart, S., and Berg, P. A. (1993) Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin. Exp. Immunol. 92, 308-316
24. Invernizzi, P., Crosignani, A., Battezzati, P. M., Covini, G., De Valle, G., Larghi, A., Zuin, M., and Podda, M. (1997) Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 25, 1090-1095
25. Jones, D. E. (2008) Pathogenesis of primary biliary cirrhosis. Clin. Liver Dis. 12, 305-321
26. Selmi, C., Zuin, M., and Gershwin, M. E. (2008) The unfinished business of primary biliary cirrhosis. J. Hepatol. 49, 451-460
27. Worman, H. J., and Courvalin, J. C. (2003) Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun. Rev. 2, 211-217
28. Yang, W. H., Yu, J. H., Nakajima, A., Neuberg, D., Lindor, K., and Bloch, D. B. (2004) Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clin. Gastroenterol. Hepatol. 2, 1116-1122
29. Rigopoulou, E. I., Davies, E. T., Pares, A., Zachou, K., Liaskos, C., Bogdanos, D. P., Rodes, J., Dalekos, G. N., and Vergani, D. (2005) Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54, 528-532
30. Muratori, L., Granito, A., Muratori, P., Pappas, G., and Bianchi, F. B. (2008) Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: Diagnostic and prognostic value. Clin. Liver Dis. 12, 261-276
31. Worman, H. J. (2007) Nuclear envelope protein autoantigens in primary biliary cirrhosis. Hepatol. Res. 37, (Suppl. 3) S406-S411
32. Granito, A., Yang, W. H., Muratori, L., Lim, M. J., Nakajima, A., Ferri, S., Pappas, G., Quarneti, C., Bianchi, F. B., Bloch, D. B., and Muratori, P. (2010) PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. Am. J. Gastroenterol. 105, 125-131
33. Parveen, S., Morshed, S. A., and Nishioka, M. (1995) High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: Nuclear immunofluorescence patterns and ELISA reactivities. J. Gastroenterol. Hepatol. 10, 438-445
34. Wesierska-Gadek, J., Penner, E., Battezzati, P. M., Selmi, C., Zuin, M., Hitchman, E., Worman, H. J., Gershwin, M. E., Podda, M., and Invernizzi, P. (2006) Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 43, 1135-1144
35. Nakamura, M., Kondo, H., Mori, T., Komori, A., Matsuyama, M., Ito, M., Takii, Y., Koyabu, M., Yokoyama, T., Migita, K., Daikoku, M., Abiru, S., Yatsuhashi, H., Takezaki, E., Masaki, N., Sugi, K., Honda, K., Adachi, H., Nishi, H., Watanabe, Y., Nakamura, Y., Shimada, M., Komatsu, T., Saito, A., Saoshiro, T., Harada, H., Sodeyama, T., Hayashi, S., Masumoto, A., Sando, T., Yamamoto, T., Sakai, H., Kobayashi, M., Muro, T., Koga, M., Shums, Z., Norman, G. L., and Ishibashi, H. (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45, 118-127
36. Gao, L., Tian, X., Liu, B., and Zhang, F. (2008) The value of antinuclear antibodies in primary biliary cirrhosis. Clin. Exp. Med. 8, 9-15
37. Bogdanos, D. P., and Komorowski, L. (2011) Disease-specific autoantibodies in primary biliary cirrhosis. Clin. Chim. Acta 412, 502-512
38. Invernizzi, P. (2007) Antinuclear antibodies: General introduction. In: Shoenfeld, M. D. Y., Gershwin, M. M. E., and Meroni, M. D. P. L., eds. Autoantibodies, 2nd Ed., pp. 129-133, Elsevier, Burlington, MA
39. Fritzler, M. J., Rattner, J. B., Luft, L. M., Edworthy, S. M., Casiano, C. A., Peebles, C., and Mahler, M. (2011) Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. Autoimmun. Rev. 10, 194-200
40. Nakano, M., Ohuchi, Y., Hasegawa, H., Kuroda, T., Ito, S., and Gejyo, F. (2000) Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J. Rheumatol. 27, 1403-1407
41. Russo, K., Hoch, S., Dima, C., Varga, J., and Teodorescu, M. (2000) Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. J. Rheumatol. 27, 142-148
42. Atalay, C., Dogan, L., and Atalay, G. (2010) Anti-CENP-B antibodies are associated with prolonged survival in breast cancer. Future Oncol. 6, 471-477
43. Bencimon, C., Salles, G., Moreira, A., Guyomard, S., Coiffier, B., Bienvenu, J., and Fabien, N. (2005) Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma. Ann. N.Y. Acad. Sci. 1050, 319-326
44. Youssef, W. I., and Tavill, A. S. (2002) Connective tissue diseases and the liver. J. Clin. Gastroenterol. 35, 345-349
45. Siegel, J. L., Luthra, H., Donlinger, J., Angulo, P., and Lindor, K. (2003) Association of primary biliary cirrhosis and rheumatoid arthritis. J. Clin. Rheumatol. 9, 340-343
46. Rigamonti, C., Shand, L. M., Feudjo, M., Bunn, C. C., Black, C. M., Denton, C. P., and Burroughs, A. K. (2006) Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 55, 388-394
47. Assassi, S., Fritzler, M. J., Arnett, F. C., Norman, G. L., Shah, K. R., Gourh, P., Manek, N., Perry, M., Ganesh, D., Rahbar, M. H., and Mayes, M. D. (2009) Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J. Rheumatol. 36, 2250-2256
48. Invernizzi, P., Selmi, C., Ranftler, C., Podda, M., and Wesierska-Gadek, J. (2005) Antinuclear antibodies in primary biliary cirrhosis. Semin. Liver Dis. 25, 298-310
49. Mayo, M. J. (2008) Natural history of primary biliary cirrhosis. Clin. Liver Dis. 12, 277-288
50. Gershwin, M. E., Mackay, I. R., Sturgess, A., and Coppel, R. L. (1987) Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J. Immunol. 138, 3525-3531
51. Stoevesandt, O., Taussig, M. J., and He, M. (2009) Protein microarrays: High-throughput tools for proteomics. Expert Rev. Proteomics 6, 145-157
52. Song, Q., Liu, G., Hu, S., Zhang, Y., Tao, Y., Han, Y., Zeng, H., Huang, W., Li, F., Chen, P., Zhu, J., Hu, C., Zhang, S., Li, Y., Zhu, H., and Wu, L. (2010) Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology. J. Proteome Res. 9, 30-39
53. Chen, C. S., Sullivan, S., Anderson, T., Tan, A. C., Alex, P. J., Brant, S. R., Cuffari, C., Bayless, T. M., Talor, M. V., Burek, C. L., Wang, H., Li, R., Datta, L. W., Wu, Y., Winslow, R. L., Zhu, H., and Li, X. (2009) Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip. Mol. Cell. Proteomics 8, 1765-1776
54. Hueber, W., Kidd, B. A., Tomooka, B. H., Lee, B. J., Bruce, B., Fries, J. F., Sønderstrup, G., Monach, P., Drijfhout, J. W., van Venrooij, W. J., Utz, P. J., Genovese, M. C., and Robinson, W. H. (2005) Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. 52, 2645-2655
55. Quintana, F. J., Farez, M. F., Viglietta, V., Iglesias, A. H., Merbl, Y., Izquierdo, G., Lucas, M., Basso, A. S., Khoury, S. J., Lucchinetti, C. F., Cohen, I. R., and Weiner, H. L. (2008) Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 105, 18889-18894
56. Babel, I., Barderas, R., Díaz-Uriarte, R., Martínez- Torrecuadrada, J. L., Sánchez-Carbayo, M., and Casal, J. I. (2009) Identification of tumourassociated autoantigens for the diagnosis of colorectal cancer in serum using high-density protein microarrays. Mol. Cell. Proteomics 8, 2382-2395
57. Auger, I., Balandraud, N., Rak, J., Lambert, N., Martin, M., and Roudier, J. (2009) New autoantigens in rheumatoid arthritis (RA): Screening 8268 protein arrays with sera from patients with RA. Ann. Rheum. Dis. 68, 591-594
58. Vigil, A., Ortega, R., Nakajima-Sasaki, R., Pablo, J., Molina, D. M., Chao, C. C., Chen, H. W., Ching, W. M., and Felgner, P. L. (2010) Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray. Proteomics 10, 2259-2269
59. Vigh-Conrad, K. A., Conrad, D. F., and Preuss, D. (2010) A protein allergen microarray detects specific IgE to pollen surface, cytoplasmic, and commercial allergen extracts. PLoS ONE 5, e10174
60. Vermeulen, N., de Béeck, K. O., Vermeire, S., Van Steen, K., Michiels, G., Ballet, V., Rutgeerts, P., and Bossuyt, X. (2011) Identification of a novel autoantigen in inflammatory bowel disease by protein microarray. Inflamm. Bowel Dis. 17, 1291-1300
61. Madoz-Gúrpide, J., Kuick, R., Wang, H., Misek, D. E., and Hanash, S. M. (2008) Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Mol. Cell. Proteomics 7, 268-281
62. Heathcote, E. J. (2000) Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31, 1005-1013
63. Jeong, J. S., Jiang, L., Albino, E., Marrero, J., Rho, H. S., Hu, J., Hu, S., Vera, C., Bayron-Poueymiroy, D., Rivera-Pacheco, Z. A., Ramos, L., Torres-Castro, C., Qian, J., Bonaventura, J., Boeke, J. D., Yap, W. Y., Pino, I., Eichinger, D. J., Zhu, H., and Blackshaw, S. (2012) Rapid identification of monospecific monoclonal antibodies using a human proteome microarray. Mol. Cell. Proteomics 11, 10.1074/mcp.O111.016253
64. Hu, S., Xie, Z., Onishi, A., Yu, X., Jiang, L., Lin, J., Rho, H. S., Woodard, C., Wang, H., Jeong, J. S., Long, S., He, X., Wade, H., Blackshaw, S., Qian, J., and Zhu, H. (2009) Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139, 610-622
65. Zhu, H., Bilgin, M., Bangham, R., Hall, D., Casamayor, A., Bertone, P., Lan, N., Jansen, R., Bidlingmaier, S., Houfek, T., Mitchell, T., Miller, P., Dean, R. A., Gerstein, M., and Snyder, M. (2001) Global analysis of protein activities using proteome chips. Science 293, 2101-2105
66. Guldner, H. H., Szostecki, C., Grötzinger, T., and Will, H. (1992) IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149, 4067-4073
67. Bandin, O., Courvalin, J. C., Poupon, R., Dubel, L., Homberg, J. C., and Johanet, C. (1996) Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 23, 1020-1024
68. Wesierska-Gadek, J., Hohenuer, H., Hitchman, E., and Penner, E. (1996) Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 110, 840-847
69. Lin, F., Noyer, C. M., Ye, Q., Courvalin, J. C., and Worman, H. J. (1996) Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR. Hepatology 23, 57-61
70. Luettig, B., Boeker, K. H., Schoessler, W., Will, H., Loges, S., Schmidt, E., Worman, H. J., Gershwin, M. E., and Manns, M. P. (1998) The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis. J. Hepatol. 28, 824-828
71. Bauer, A., and Habior, A. (2007) Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis. J. Clin. Lab. Anal. 21, 227-231
72. Stinton, L. M., Swain, M., Myers, R. P., Shaheen, A. A., and Fritzler, M. J. (2011) Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clin. Exp. Immunol. 163, 147-156
73. Tsangaridou, E., Polioudaki, H., Sfakianaki, R., Samiotaki, M., Tzardi, M., Koulentaki, M., Panayotou, G., Kouroumalis, E., Castanas, E., and Theodoropoulos, P. A. (2010) Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods. BMC Gastroenterol. 10, 28
74. Nickowitz, R. E., Wozniak, R. W., Schaffner, F., and Worman, H. J. (1994) Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 106, 193-199
75. Miyachi, K., Hankins, R. W., Matsushima, H., Kikuchi, F., Inomata, T., Horigome, T., Shibata, M., Onozuka, Y., Ueno, Y., Hashimoto, E., Hayashi, N., Shibuya, A., Amaki, S., and Miyakawa, H. (2003) Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: A multicenter study. J. Autoimmun. 20, 247-254
76. Kim, W. R., Ludwig, J., and Lindor, K. D. (2000) Variant forms of cholestatic diseases involving small bile ducts in adults. Am. J. Gastroenterol. 95, 1130-1138
77. Zhu, H., Hu, S., Jona, G., Zhu, X., Kreiswirth, N., Willey, B. M., Mazzulli, T., Liu, G., Song, Q., Chen, P., Cameron, M., Tyler, A., Wang, J., Wen, J., Chen, W., Compton, S., and Snyder, M. (2006) Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc. Natl. Acad. Sci. U.S.A. 103, 4011-4016
78. Walker, J. G., Doniach, D., Roitt, I. M., and Sherlock, S. (1965) Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1, 827-831
79. Doniach, D., Roitt, I. M., Walker, J. G., and Sherlock, S. (1966) Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol 1, 237-262
80. Goudie, R. B., Macsween, R. N., and Goldberg, D. M. (1966) Serological and histological diagnosis of primary biliary cirrhosis. J. Clin. Pathol. 19, 527-538
81. Yeaman, S. J., Fussey, S. P., Danner, D. J., James, O. F., Mutimer, D. J., and Bassendine, M. F. (1988) Primary biliary cirrhosis: Identification of two major M2 mitochondrial autoantigens. Lancet 1, 1067-1070
82. Courvalin, J. C., Lassoued, K., Worman, H. J., and Blobel, G. (1990) Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J. Exp. Med. 172, 961-967
83. Szostecki, C., Guldner, H. H., Netter, H. J., and Will, H. (1990) Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145, 4338-4347
84. Bloch, D. B., de la Monte, S. M., Guigaouri, P., Filippov, A., and Bloch, K. D. (1996) Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem. 271, 29198-29204
85. Hu, C. J., Zhang, F. C., Li, Y. Z., and Zhang, X. (2010) Primary biliary cirrhosis: What do autoantibodies tell us? World J. Gastroenterol. 16, 3616-3629
86. Li, C. H., Xu, P. S., Wang, C. Y., Zhang, Y., and Zou, G. L. (2006) The presence of anti-mitochondrial antibodies in Chinese patients with liver involvement in systemic lupus erythematosus. Rheumatol. Int. 26, 697-703
87. Matsushita, M., Matsudaira, R., Ikeda, K., Nawata, M., Tamura, N., and Takasaki, Y. (2009) Anti-proteasome activator 28α is a novel anti-cytoplasmic antibody in patients with systemic lupus erythematosus and Sjogren's syndrome. Mod. Rheumatol. 19, 622-628
88. Berg, P. A., and Klein, R. (1992) Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: Definition and clinical relevance. Dig. Dis. 10, 85-101
89. Feuchtinger, M., Christ, S., Preuss, B., Dengjel, J., Duman, S., Stevanovic, S., and Klein, R. (2009) Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis. Gut 58, 983-989
90. Zollman, S., Godt, D., Privé, G. G., Couderc, J. L., and Laski, F. A. (1994) The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 91, 10717-10721
91. Bardwell, V. J., and Treisman, R. (1994) The POZ domain: A conserved protein-protein interaction motif. Genes Dev. 8, 1664-1677
92. Angers, S., Thorpe, C. J., Biechele, T. L., Goldenberg, S. J., Zheng, N., MacCoss, M. J., and Moon, R. T. (2006) The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. Nat. Cell Biol. 8, 348-357
93. Adams, J., Kelso, R., and Cooley, L. (2000) The kelch repeat superfamily of proteins: Propellers of cell function. Trends Cell Biol. 10, 17-24
94. Uchida, K., Akita, Y., Matsuo, K., Fujiwara, S., Nakagawa, A., Kazaoka, Y., Hachiya, H., Naganawa, Y., Oh-Iwa, I., Ohura, K., Saga, S., Kawai, T., Matsumoto, Y., Shimozato, K., and Kozaki, K. (2005) Identification of specific autoantigens in Sjogren's syndrome by SEREX. Immunology 116, 53-63
95. Jeon, B. N., Choi, W. I., Yu, M. Y., Yoon, A. R., Kim, M. H., Yun, C. O., and Hur, M. W. (2009) ZBTB2, a novel master regulator of the p53 pathway. J. Biol. Chem. 284, 17935-17946
96. Bianchi, M., Crinelli, R., Serafini, G., Giammarini, C., and Magnani, M. (1997) Molecular bases of hexokinase deficiency. Biochim. Biophys. Acta 1360, 211-221
97. Gonzalez-Gronow, M., Cuchacovich, M., Francos, R., Cuchacovich, S., Del Pilar Fernandez, M., Blanco, A., Bowers, E. V., Kaczowka, S., and Pizzo, S. V. (2010) Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism. J. Neuroimmunol. 227, 153-161
98. Murakami, K., and Piomelli, S. (1997) Identification of the cDNA for human red blood cell-specific hexokinase isozyme. Blood 89, 762-766